IN HB1114

Prohibits "step therapy" or "fail first" requirements for prescription drugs used to treat advanced, metastatic cancer and associated conditions, meaning insurers cannot require patients to try and fail on a different drug before covering the prescribed medication

Applies to state employee health plans, accident and sickness insurance policies, and health maintenance organization contracts issued, amended, or renewed after June 30, 2026

Covered drugs must be FDA-approved, supported by peer-reviewed evidence-based literature, and consistent with best practices for treating advanced metastatic cancer or its associated symptoms and side effects

Defines "advanced, metastatic cancer" as cancer that has spread from the primary site to nearby tissues, lymph nodes, or other parts of the body

Effective July 1, 2026